News

Lucid (LCID) Stock Trades Down, Here Is Why

Shares of luxury electric car manufacturer Lucid (NASDAQ:LCID) fell 13.8% in the afternoon session after Bank of America downgraded the stock's rating from Neutral to Sell and lowered the price target from $3 to $1 following its mixed Q4 2024 earnings.

Economic deal between US and Ukraine will tie the countries together for years. Here’s what it says

A preliminary economic agreement between Ukraine and the United States would ensure long-term U.S. involvement in rebuilding the country, but the deal leaves the question of security guarantees sought by Kyiv to future negotiations. According to the final version of the deal obtained by The Associated Press, the United States and Ukraine will establish a co-owned and jointly managed investment fund aimed at financing the reconstruction of Ukraine and its war-damaged economy.

Cryptocurrency firm founder extradited from Portugal to face US fraud charges

The founder of a cryptocurrency financial services firm has been extradited from Portugal to face U.S. charges that he participated in a wide-ranging scheme to manipulate the market for digital tokens on behalf of client companies. Aleksei Andriunin, the founder and CEO of cryptocurrency "market maker" Gotbit, was ordered detained following an appearance in Boston federal court on Wednesday, one day after his extradition, the U.S. Department of Justice said. The 26-year-old Russian national during the court hearing pleaded not guilty to charges of wire fraud and conspiracy to commit market manipulation and wire fraud.

Luxfer (LXFR) Stock Trades Down, Here Is Why

Shares of speciality material and gas containment company Luxfer (NYSE:LXFR) fell 8.4% in the morning session after the company reported an underwhelming Q4 2024 result, as its full-year revenue and EBITDA guidance fell short of expectations. However, quarterly results were strong, with revenue, EPS, and EBITDA significantly surpassing analysts' estimates. Zooming out, we think this was a mixed quarter.

Why United Therapeutics (UTHR) Stock Is Down Today

Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 10.9% in the afternoon session after the company reported disappointing fourth-quarter results: EPS missed analysts' expectations, and sales were underwhelming, coming in line with expectations. We struggled to find many positives in these results, especially because EPS missed. Overall, this quarter could have been better​.

Why Zeta (ZETA) Stock Is Down Today

Shares of advertising and marketing company Zeta Global (NYSE:ZETA) fell 13.8% in the pre-market session after the company reported weak fourth quarter 2024 results as its revenue guidance for next year suggests a significant slowdown in demand, and its revenue guidance for next quarter fell slightly short of Wall Street's estimates. On the other hand, Zeta reported optimistic EBITDA guidance for the next quarter, which blew past analysts' expectations, and its full-year EBITDA guidance trumped